一种基因选,以揭示在膜接触部位的脂质转移蛋白功能背后的机制
Shirish Mishra1, Vaishnavi Manohar1, Shabnam Chandel1
1National Centre for Biological Sciences-TIFR, GKVK Campus, Bangalore, India.
Life science alliance
|March 18, 2024
概括
视网膜退化B (RDGB) 蛋白功能丧失导致神经退化. 这项研究确定了新的脂质调节剂和转录/无化途径,涉及RDGB介导的视网膜退化.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 脂质转移蛋白对于有机细胞膜功能至关重要.
- 脂质转移蛋白功能的丧失与神经退行有关,但机制尚不清楚.
- 视网膜退化B (RDGB) 是一种酸氨基转移蛋白,涉及到Drosophila光受体退化.
研究的目的:
- 阐明 RDGB 功能障碍导致视网膜退化的机制.
- 为了在体内确定RDGB功能的调节者.
- 探索新型脂质和转录/ubiquitination过程在神经退行症中的作用.
主要方法:
- 在Drosophila中300多个VAP相互作用蛋白的耗尽.
- 基因查以确定rdgB的抑制剂.
- 对已识别的抑制剂的分子特性的分析.
主要成果:
- 确定了52种rdgB抑制剂.
- 鉴定到的抑制剂表明了新型脂质在调节RDGB中的作用.
- 转录和无处不在的过程与rdgB突变体的视网膜退化有关.
结论:
- 通过VAP介导的相互作用对RDGB功能至关重要.
- 新型脂质和调节途径参与了与RDGB相关的神经退行.
- 已识别的分子的人类同类与神经发育性疾病有关,突出显示了保留的机制.
更多相关视频
10:49Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy
Published on: March 5, 2017
13.3K
07:37Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening
Published on: May 13, 2020
1.9K
相关概念视频
Genetic Screens
4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
